Skip to main content
NCBI home page
Molecular Genetics & Genomic Medicine logoLink to Molecular Genetics & Genomic Medicine
. 2019 Sep 16;7(11):e977. doi: 10.1002/mgg3.977

Keratin 9 L164P mutation in a Chinese pedigree with epidermolytic palmoplantar keratoderma, cytokeratin analysis, and literature review

Xiaoliang Liu 1, Chuang Qiu 2, Rong He 1, Yuanyuan Zhang 1, Yanyan Zhao 1,✉
PMCID: PMC6825865  PMID: 31525823

Abstract

Background

Epidermolytic palmoplantar keratoderma (EPPK) is characterized by hyperkeratotic lesions on palms and soles. The disorder is caused by mutations of keratin 9 (KRT9) or KRT1 gene.

Methods

Epidermolytic palmoplantar keratoderma was diagnosed by physical examination and histopathological analysis in a five‐generation Chinese family. Mutation was screened by Sanger sequencing. The palmar expression of multiple cytokeratins were analyzed by tape‐stripping and Real‐time PCR. Literatures of EPPK with additional symptoms were reviewed.

Results

Affected family members showed diffuse palmoplantar keratosis, with knuckle pads, friction‐related lesions and a novel additional symptom of palmar constriction. A heterozygous mutation of c.T491C (p.L164P) of KRT9 was found within the helix initiation motif. The hydrophobic effect was decreased and the initiation of coiled‐coil conformation was delayed. The KRT16/KRT6 expression were significantly increased in the patients, especially on the right, indicating activation of stress‐response and wound‐healing cytokeratins. There were also increased KRT9/KRT2, unchanged KRT10/KRT1, and undetectable KRT14/KRT5 expression. The genetic and phenotypic heterogeneity of EPPK with additional symptoms were summarized by literature review.

Conclusion

The p.L164P mutation of KRT9 caused EPPK with a novel symptom of palmar constriction. The expression of multiple cytokeratins was altered in EPPK patients.

Keywords: cytokeratin, EPPK, intermediate filament, KRT9, mutation

1. INTRODUCTION

Epidermolytic palmoplantar keratoderma (EPPK, OMIM 144200) is an autosomal dominant genodermatosis that manifests as hyperkeratosis confined to the palms and soles (Reis et al., 1994). The prime genetic candidate for EPPK is the keratin 9 (KRT9) gene on chromosome 17q21 wherein type I keratin gene cluster is located (Langbein, Heid, Moll, & Franke, 1993). KRT9 is exclusively expressed in the suprabasal layers of palmoplantar epidermis, and is essential for maintaining mechanical integrity of palmoplantar epidermis. It is structurally composed of a central rod α‐helical domain, flanked by non‐helical head and tail domains. Mutations of KRT9 associated with EPPK usually occur in the helix initiation motif (HIM) or in the 1A rod domain close to HIM. Another less‐often candidate of EPPK is the KRT1 gene belonging to type II keratin family on chromosome 12q13 (Hatsell et al., 2001).

Mutations of many EPPK cases are recurrent among different populations, yet the clinical manifestations are not the same. Some cases are associated with knuckle pads, nail lesions, and camptodactyly. We reported a novel symptom of palmar constriction in a Chinese EPPK pedigree in this study. We showed for the first time that heterozygous p.L164P mutation of KRT9 associated with altered expression of multiple cytokeratins in EPPK patients.

2. MATERIALS AND METHODS

2.1. Patients

A five‐generation family with EPPK from Northeast China was included in this study. Peripheral blood samples were obtained from five affected and five unaffected family members. We followed the Declaration of Helsinki, and all protocols were approved by the Ethics Committee of Shengjing Hospital of China Medical University. All the participants were well informed, and consented for data publication in written.

2.2. Histopathologic analysis

Skin biopsy from the left palm of the proband was performed for histopathologic analysis. Photomicrographs were taken by OLYMPS IX51 inverted microscope (Olympus).

2.3. Mutation analysis

Genomic DNA from peripheral blood samples was isolated using the Blood Genomic DNA Miniprep Kit (Axygen). All the exons and the flanking splice junctions of KRT9 were bidirectionally sequenced on ABI Prism 3730 Genetic Analyzer (Applied Biosystems). All primers in this study were designed using online software. The conservation and homology of sequences were assayed by the NCBI online resources (http://www.ncbi.nlm.nih.gov/). The protein secondary structure was analyzed by Expasy (http://www.expasy.org/).

2.4. Tape stripping and RNA isolation

Tape stripping was applied on the palms of five affected and five unaffected family members. Briefly, an area of 25 × 25 mm was repeatedly stripped for eight times by adhesive tapes (Sellotape GB Ltd.). Tapes were removed after a 2‐min adhesion with gentle pressure, rolled with the adhesive side out, and stored in individual tubes at −80°C until extraction. The stripping was performed three times with one‐month interval. The skin cells adherent to all tapes were pooled in one volume of buffer RLT and the RNA was isolated using RNeasy RNA extraction kit (Qiagen).

2.5. Reverse transcription and Real‐time PCR

Total RNA was reverse transcribed into cDNA using Sensiscript Reverse Transcriptase kit (Qiagen). Real‐time PCR was performed using the ABI 7900 System with all reagents purchased from Applied Biosystems. The expression of wild‐type and mutant KRT9 mRNA was assayed by Taqman method, with probes FAM‐TTCTCGGCTGGCCTCTTAC‐MGB and VIC‐TTCTCGGCCGGCCTCTTAC‐MGB, respectively. The relative expression of KRT9/KRT2, KRT16/KRT6, KRT10/KRT1, and KRT14/KRT5 were assayed by SYBR Green method. The β‐actin transcript was used as an internal control.

2.6. Statistical analysis

Statistical analysis was run using SPSS 16.0 software (SPSS). Data are presented by mean ± SD. Statistical differences were determined by independent‐sample t test. A value of p < .05 was considered significant.

3. RESULTS

3.1. Clinical findings

The hyperkeratosis was inherited in autosomal‐dominant pattern in the pedigree (Figure 1a). All affected individuals had similar symptoms. Epidermal hyperkeratosis started at age around 3 months. Diffuse yellowish thickening of the palmoplantar skin was surrounded by erythematous borders (Figure 1b). Knuckle pads were on the dorsal aspect of proximal interphalangeal joints. The hyperkeratosis and knuckle pads were more severe on the right, indicating friction‐related lesions. The frequently used right hands were irrationally smaller than the left. For the proband, the maximum width encompassing thenar muscles was 9.8 cm on the left and 8.1 cm on the right, indicating palmar constriction. There were mild decrease in heat and tactile sensitivity, slight difficulty in finger flexion, and fissuring on the feet. No other abnormalities were observed. Histopathologic analysis showed hyperplasia and hyperkeratosis, associated with hypergranulosis and acanthosis. Vacuolated cells were visible in the suprabasal layer (Figure 1c).

Figure 1.

Figure 1

Open in a new tab

(a) Pedigree of the EPPK family. (b) Clinical presentation. There were diffuse yellowish thickening with erythematous margins on the palms and soles. Palm hyperkeratosis and knuckle pads were more severe on the right. The right palm was smaller than the left. (c) Histological presentation. The arrows indicate vacuolated cells. The bar represents 50 μm in image of ×400. (d) Sanger sequencing of the KRT9 gene. The heterozygous variation in c.T491C (p.L164P) was found in the patient, not in the control

3.2. Mutation analysis

All exons of KRT9 were sequenced, showing a heterozygous c.T491C (p.L164P) variation in patients but not in unaffected controls (Figure 1d). The mutation resides at the second a residue of the heptad repeats (abcdefg). It is highly conserved and homologous. The hydropathy index decreased from +3.8 of leucine to −1.6 of proline (Kyte & Doolittle, 1982). The protein secondary structure was assayed by Expasy, showing delayed initiation of the coiled‐coil conformation (Figure S1). We reviewed literature and the mutation was recurrent (Mao, Zhang, You, Xiao, & Zhao, 2018). We listed all the additional symptoms of EPPK with KRT9 mutations in Table 1, with our data added in.

Table 1.

Additional symptoms of EPPK with KRT9 gene mutations

cDNA mutationa Protein mutationa Domain Additional symptoms
c.A469G p.M157V 1A Blister (Hennies et al., 1994)
c.T470C p.M157T 1A Knuckle pad (Chen et al., 2009)
c.T470G p.M157R 1A Knuckle pad, camptodactyly and nails lesions (Liang et al., 2014)
c.C478T p.L160F 1A Knuckle pad and friction‐related lesion (Lu et al., 2003)
c.A481T p.N161Y 1A Cosegregate with breast and ovarian cancer (Torchard et al., 1994)
c.A482G p.N161S 1A Knuckle pad, (Li et al., 2019; Mao et al., 2018) hyperhidrosis and camptodactyly (Li et al., 2019)
c.A482T p.N161I 1A Knuckle pad and nail lesions (Küster et al., 2002)
c.C487T p.R163W 1A Knuckle pad, (Chiu et al., 2007; Codispoti et al., 2009; Lopez‐Valdez et al., 2013; Mao et al., 2018; Rothnagel et al., 1995; Xu et al., 2009) friction‐related lesion, (Chiu et al., 2007; Funakushi et al., 2009; Mayuzumi et al., 1999) blister, (Navsaria et al., 1995) parchment‐like scaling, (Warmuth et al., 2000)
digital constriction, (Funakushi et al., 2009; Umegaki et al., 2011) camptodactyly (Lopez‐Valdez et al., 2013; Mao et al., 2018)
c.T491C p.L164P 1A Knuckle pad, palmar constriction, friction‐related lesions (this report)
c.T503C p.L168S 1A Knuckle pad (Li et al., 2009)
c.T1216C p.C406R 2B Knuckle pad (Wang et al., 2010)
c.C1282T p.Q428X 2B Knuckle pad (Umegaki et al., 2011)
c.T1373C p.L458P 2B Knuckle pad and camptodactyly (Du et al., 2011)
Open in a new tab
a

Unified according to new version of KRT9 sequence [GI:13653405].

3.3. Cytokeratin expression analysis

Palmar epidermal cells were harvested non‐invasively by tape‐stripping. The total output of RNA was significantly higher in the patients than controls (left: 255.6 ± 49.2 vs. 28.3 ± 6.5 ng, p < .01; right: 276.8 ± 61.4 vs. 30.6 ± 6.2 ng, p < .01). Both wild‐type and mutant KRT9 mRNA were detectable in the patients (Figure 2a). We furthermore analyzed the expression of keratin pairs KRT9/KRT2, KRT16/KRT6, KRT10/KRT1, and KRT14/KRT5 (Figure 2b). The relative expression of KRT9 was higher in the patients than controls (p < .01). There was also an increase of KRT2, the partner keratin of KRT9 (p < .05). The stress‐activated KRT16/KRT6 were obviously upregulated in the patients than controls (p < .01). Moreover, the right palms showed even higher levels of KRT16/KRT6 than the left in the patients (p < .01). The expression levels of KRT10/KRT1 were not changed. The expression of KRT14/KRT5 were not detectable in both groups (data not shown). Overall, the KRT9 p.L164P mutation altered the expression of multiple cytokeratins in the palmar epidermis.

Figure 2.

Figure 2

Open in a new tab

(a) Both wild‐type and mutant KRT9 were detectable in the patient, not in the control by Taqman method of Real‐time PCR. (b) Relative expression of KRT9/KRT2, KRT16/KRT6, and KRT10/KRT1 were assayed by quantitative Real‐time PCR, with the β‐actin mRNA as internal control. The bars are graphed as mean ± SD of fold over control left that is taken as “1.” Each sample was amplified in triplicates for at least three independent experiments. *: p < .05 compared with the control; **: p < .01 compared with the control; #: p < .01 compared with the left

4. DISCUSSION

Mutations of most EPPK cases are recurrent among different populations, yet the clinical manifestations are not always the same, not only in the severity of keratosis but also in additional symptoms. The present Chinese EPPK pedigree showed typical clinical and histopathological features. There were three additional symptoms: knuckle pads, friction‐related lesions and palmar constriction. By reviewing literature, 22 cases of EPPK with KRT9 mutations showed additional symptoms. Knuckle pads happened in 15 cases and are the most common accompanying EPPK (68%). There were 11 KRT9 mutations scattering from 1A to 2B domain for EPPK with knuckle pads, showing no specific mutation site (Chen, Xu, Cai, Chen, & Zhang, 2009; Chiu et al., 2007; Codispoti et al., 2009; Du et al., 2011; Küster, Reis, & Hennies, 2002; Li, Yang, Hua, Zhu, & Dai, 2009; Li et al., 2019; Liang, Liu, Huang, & Zeng, 2014; Lopez‐Valdez, Rivera‐Vega, Gonzalez‐Huerta, Cazarin, & Cuevas‐Covarrubias, 2013; Lu et al., 2003; Mao et al., 2018; Rothnagel et al., 1995; Umegaki et al., 2011; Wang, He, Song, Liu, & Chen, 2010; Xu, Chen, Chen, & Zhang, 2009). Ectopic expression of KRT9 was found in the pad, which might be responsible for the pad formation (Codispoti et al., 2009). Friction‐related lesions (18%) have been reported in Chinese, Indian, and Japanese patients with p.L160F and p.R163W mutations (Chiu et al., 2007; Funakushi, Mayuzumi, Sugimura, & Ikeda, 2009; Lu et al., 2003; Mayuzumi, Shigihara, Ikeda, & Ogawa, 1999). It is possible that the morbid epidermis might compensate for the decreased stability by overgrowing in response to mechanical friction, leading to hyperkeratosis in the frequently used hand. Palmar constriction is a novel finding, which is different from digital constriction in two Japanese patients with p.R163W mutation (Funakushi et al., 2009; Umegaki et al., 2011). Digital constriction occurred in the interphalangeal joints without hyperkeratosis, whereas palmar constriction occurred in the most hyperkeratotic regions. We are not sure whether the palmar constriction was due to merely reduced extension of the thick epidermal plaques, or to involvement of some deeper tissues. Other phenotypes have been reported in some studies such as camptodactyly (23%, Du et al., 2011; Li et al., 2019; Liang et al., 2014; Lopez‐Valdez et al., 2013; Mao et al., 2018), nail lesions (Küster et al., 2002; Liang et al., 2014), blister (Hennies, Zehender, Kunze, Küster, & Reis, 1994; Navsaria et al., 1995), scaling (Warmuth, Cserhalmi‐Friedman, Schneiderman, Grossman, & Christiano, 2000), hyperhidrosis (Li et al., 2019), and cosegregation with breast and ovarian cancer (Torchard et al., 1994). They were not found in our case. Overall, symptoms differ greatly even in cases carrying the same mutation. The diversity might lie in environmental or epigenetic factors, and needs further experiments on animals with specific krt9 gene mutations.

Keratin family type I and II assemble to form heterodimers through coiled‐coil interaction of the rod domain composed by heptad repeats (abcdefg). Residues at position a and d stabilize dimer formation through hydrophobic effects (Langbein et al., 1993). The p.L164P at the second a position caused a great decrease in hydrophobic level, which should influence the formation and stability of heterodimers. Secondary structure analysis showed delayed initiation of the coiled‐coil conformation, indicating the mutation might be functional influencing.

Tape stripping is an effective and non‐invasive way to recover epidermal cells for RNA or protein assays (Wong et al., 2004). The krt9−/− mice had hyperpigmented calluses in the footpads and abnormal expression of many keratins (Fu et al., 2014). Hereby, the impact of KRT9 p.L164P mutation on cytokeratin expression was analyzed by tape‐stripping and Real‐time PCR. The patients were more susceptible to loose cells and the RNA output was much higher. Both wild‐type and mutant KRT9 were expressed in the patients. The mutation caused an increase in total abundance of KRT9 and its partner KRT2. There was great induction of stress‐response and wound‐healing KRT16/KRT6, with even higher levels on the right, indicating activated signals of hyperproliferation in response to friction. KRT10/KRT1 expressed predominantly in normal epidermis were not altered by the mutation. KRT14/KRT5 expressed in undifferentiated cells of basal layer were not detectable, probably because tape‐stripping collected upper epidermis cells. Overall, the KRT9 p.L164P mutation disturbed the expression of multiple cytokeratins.

In summary, we reported a Chinese EPPK family with a novel symptom of palmar constriction, which expanded the versatility of EPPK by literature review. We provided data about varied expression of cytokeratins in EPPK patients.

CONFLICT OF INTEREST

The authors stated no conflict of interest.

AUTHORS’ CONTRIBUTION

X.L. designed the experiment, analyzed the data, and drafted the manuscript. C.Q. acquired the clinical and pathological data. R.H. did the molecular experiments. Y.Zhang reviewed literature. Y.Zhao oversaw the study and revised the manuscript.

Supporting information

 

Click here for additional data file. (18.6MB, doc)

ACKNOWLEDGMENTS

We thank all the participants of this study. This study was supported by grants from National Natural Science Foundation of China (81100187) and National Key Technologies R&D Program of China (2016YFC1000702).

Liu X, Qiu C, He R, Zhang Y, Zhao Y. Keratin 9 L164P mutation in a Chinese pedigree with epidermolytic palmoplantar keratoderma, cytokeratin analysis, and literature review. Mol Genet Genomic Med. 2019;7:e977 10.1002/mgg3.977

Funding information

This study was supported by grants from National Natural Science Foundation of China (81100187) and National Key Technologies R&D Program of China (2016YFC1000702).

REFERENCES

  1. Chen, X. L. , Xu, C. M. , Cai, S. R. , Chen, C. Y. , & Zhang, X. N. (2009). Prenatal diagnosis of epidermolytic palmoplantar keratoderma caused by c.T470C (p. M157T) of the keratin 9 gene in a Chinese kindred. Prenatal Diagnosis, 29, 911–913. 10.1002/pd.2315 [DOI] [PubMed] [Google Scholar]
  2. Chiu, H. C. , Jee, S. H. , Sheen, Y. S. , Chu, C. Y. , Lin, P. J. , & Liaw, S. H. (2007). Mutation of keratin 9 (R163W) in a family with epidermolytic palmoplantar keratoderma and knuckle pads. Journal of Dermatological Science, 45, 63–65. 10.1016/j.jdermsci.2006.09.005 [DOI] [PubMed] [Google Scholar]
  3. Codispoti, A. , Colombo, E. , Zocchi, L. , Serra, V. , Pertusi, G. , Leigheb, G. , … Terrinoni, A. (2009). Knuckle pads, in an epidermal palmoplantar keratoderma patient with Keratin 9 R163W transgrediens expression. European Journal of Dermatology, 19, 114–118. 10.1684/ejd.2008.0575 [DOI] [PubMed] [Google Scholar]
  4. Du, Z.‐F. , Wei, W. , Wang, Y.‐F. , Chen, X.‐L. , Chen, C.‐Y. , Liu, W.‐T. , … Zhang, X.‐N. (2011). A novel mutation within the 2B rod domain of keratin 9 in a Chinese pedigree with epidermolytic palmoplantar keratoderma combined with knuckle pads and camptodactyly. European Journal of Dermatology, 21, 675–679. 10.1684/ejd.2011.1458 [DOI] [PubMed] [Google Scholar]
  5. Fu, D. J. , Thomson, C. , Lunny, D. P. , Dopping‐Hepenstal, P. J. , McGrath, J. A. , Smith, F. J. D. , … Leslie Pedrioli, D. M. (2014). Keratin 9 is required for the structural integrity and terminal differentiation of the palmoplantar epidermis. Journal of Investigative Dermatology, 134(3), 754–763. 10.1038/jid.2013.356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Funakushi, N. , Mayuzumi, N. , Sugimura, R. , & Ikeda, S. (2009). Epidermolytic palmoplantar keratoderma with constriction bands on bilateral fifth toes. Archives of Dermatology, 145, 609–610. 10.1001/archdermatol.2009.83 [DOI] [PubMed] [Google Scholar]
  7. Hatsell, S. J. , Eady, R. A. , Wennerstrand, L. , Dopping‐Hepenstal, P. , Leigh, I. M. , Munro, C. , & Kelsell, D. P. (2001). Novel splice site mutation in keratin 1 underlies mild epidermolytic palmoplantar keratoderma in three kindreds. The Journal of Investigative Dermatology, 116, 606–609. 10.1046/j.1523-1747.2001.13041234.x [DOI] [PubMed] [Google Scholar]
  8. Hennies, H. C. , Zehender, D. , Kunze, J. , Küster, W. , & Reis, A. (1994). Keratin 9 gene mutational heterogeneity in patients with epidermolytic palmoplantar keratoderma. Human Genetics, 93, 649–654. 10.1007/bf00201564 [DOI] [PubMed] [Google Scholar]
  9. Küster, W. , Reis, A. , & Hennies, H. C. (2002). Epidermolytic palmoplantar keratoderma of Vörner: Re‐evaluation of Vörner's original family and identification of a novel keratin 9 mutation. Archives of Dermatological Research, 294, 268–272. 10.1007/s00403-002-0328-9 [DOI] [PubMed] [Google Scholar]
  10. Kyte, J. , & Doolittle, R. F. (1982). A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology, 157, 105–132. 10.1016/0022-2836(82)90515-0 [DOI] [PubMed] [Google Scholar]
  11. Langbein, L. , Heid, H. W. , Moll, I. , & Franke, W. W. (1993). Molecular characterization of the body site‐specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression. Differentiation, 55, 57–71. 10.1111/j.1432-0436.1993.tb00033.x [DOI] [PubMed] [Google Scholar]
  12. Li, M. , Yang, L. J. , Hua, H. K. , Zhu, X. H. , & Dai, X. Y. (2009). Keratin‐9 gene mutation in epidermolytic palmoplantar keratoderma combined with knuckle pads in a large Chinese family. Clinical and Experimental Dermatology, 34, 26–28. 10.1111/j.1365-2230.2007.02384.x [DOI] [PubMed] [Google Scholar]
  13. Li, Y. , Tang, L. , Han, Y. , Zheng, L. , Zhen, Q. , Yang, S. , & Gao, M. (2019). Genetic analysis of KRT9 gene revealed previously known mutations and genotype‐phenotype correlations in epidermolytic palmoplantar keratoderma. Frontiers in Genetics, 7, 645 10.3389/fgene.2018.00645 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Liang, Y. H. , Liu, Q. X. , Huang, L. , & Zeng, K. (2014). A recurrent p. M157R mutation of keratin 9 gene in a Chinese family with epidermolytic palmoplantar keratoderma and literature review. International Journal of Dermatology, 53, e375–e379. 10.1111/ijd.12352 [DOI] [PubMed] [Google Scholar]
  15. Lopez‐Valdez, J. , Rivera‐Vega, M. R. , Gonzalez‐Huerta, L. M. , Cazarin, J. , & Cuevas‐Covarrubias, S. (2013). Analysis of the KRT9 gene in a Mexican family with epidermolytic palmoplantar keratoderma. Pediatric Dermatology, 30, 354–358. 10.1111/pde.12027 [DOI] [PubMed] [Google Scholar]
  16. Lu, Y. , Guo, C. , Liu, Q. , Zhang, X. , Cheng, L. , Li, J. , … Gong, Y. (2003). A novel mutation of keratin 9 in epidermolytic palmoplantar keratoderma combined with knuckle pads. American Journal of Medical Genetics, 120A, 345–349. 10.1002/ajmg.a.20090 [DOI] [PubMed] [Google Scholar]
  17. Mao, B. , Zhang, J. , You, Y. , Xiao, J. , & Zhao, X. (2018). Mutations in the highly conserved 1A rod domain of keratin 9 responsible for epidermolytic palmoplantar keratoderma in four Chinese families. The Journal of Dermatology, 45, e45–e46. 10.1111/1346-8138.14087 [DOI] [PubMed] [Google Scholar]
  18. Mayuzumi, N. , Shigihara, T. , Ikeda, S. , & Ogawa, H. (1999). R162W mutation of keratin 9 in a family with autosomal dominant palmoplantar keratoderma with unique histologic features. Journal of Investigative Dermatology Symposium Proceedings, 4(2), 150–152. 10.1038/sj.jidsp.5640199 [DOI] [PubMed] [Google Scholar]
  19. Navsaria, H. A. , Swensson, O. , Ratnavel, R. C. , Shamsher, M. , Irwin McLean, W. H. , Birgitte Lane, E. , … Leigh, I. M. (1995). Ultrastructural changes resulting from keratin‐9 gene mutations in two families with epidermolytic palmoplantar keratoderma. The Journal of Investigative Dermatology, 104, 425–429. 10.1111/1523-1747.ep12666011 [DOI] [PubMed] [Google Scholar]
  20. Reis, A. , Hennies, H.‐C. , Langbein, L. , Digweed, M. , Mischke, D. , Drechsler, M. , … Küster, W. (1994). Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nature Genetics, 6, 174–179. 10.1038/ng0294-174 [DOI] [PubMed] [Google Scholar]
  21. Rothnagel, J. A. , Wojcik, S. , Liefer, K. M. , Dominey, A. M. , Huber, M. , Hohl, D. , & Roop, D. R. (1995). Mutations in the 1A domain of keratin 9 in patients with epidermolytic palmoplantar keratoderma. The Journal of Investigative Dermatology, 104, 430–433. 10.1111/1523-1747.ep12666018 [DOI] [PubMed] [Google Scholar]
  22. Torchard, D. , Blanchet‐Bardon, C. , Serova, O. , Langbein, L. , Narod, S. , Janin, N. , … Feunteun, J. (1994). Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nature Genetics, 6, 106–110. 10.1038/ng0194-106 [DOI] [PubMed] [Google Scholar]
  23. Umegaki, N. , Nakano, H. , Tamai, K. , Mitsuhashi, Y. , Akasaka, E. , Sawamura, D. , & Katayama, I. (2011). Vörner type palmoplantar keratoderma: Novel KRT9 mutation associated with knuckle pad‐like lesions and recurrent mutation causing digital mutilation. The British Journal of Dermatology, 165, 199–201. 10.1111/j.1365-2133.2011.10317.x [DOI] [PubMed] [Google Scholar]
  24. Wang, K. , He, C. D. , Song, F. , Liu, J. , & Chen, H. D. (2010). A novel mutation of the keratin 9 gene in a Chinese family with epidermolytic palmoplantar keratoderma. International Journal of Dermatology, 49, 1342–1344. 10.1111/j.1365-4632.2009.04295.x [DOI] [PubMed] [Google Scholar]
  25. Warmuth, I. , Cserhalmi‐Friedman, P. B. , Schneiderman, P. , Grossman, M. E. , & Christiano, A. M. (2000). Epidermolytic palmoplantar keratoderma in a Hispanic kindred resulting from a mutation in the keratin 9 gene. Clinical and Experimental Dermatology, 25, 244–246. [DOI] [PubMed] [Google Scholar]
  26. Wong, R. , Tran, V. , Morhenn, V. , Hung, S.‐P. , Andersen, B. , Ito, E. , … Benson, N. R. (2004). Use of RT‐PCR and DNA microarrays to characterize RNA recovered by non‐invasive tape harvesting of normal and inflamed skin. The Journal of Investigative Dermatology, 123, 159–167. 10.1111/j.0022-202X.2004.22729.x [DOI] [PubMed] [Google Scholar]
  27. Xu, C. M. , Chen, X. L. , Chen, C. Y. , & Zhang, X. N. (2009). Missense mutation of keratin 9 (c.487C>T (p. R163W) in southern Chinese patients with epidermolytic palmoplantar keratoderma. European Journal of Dermatology : EJD, 19, 265–266. 10.1684/ejd.2009.0631 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

 

Click here for additional data file. (18.6MB, doc)

Articles from Molecular Genetics & Genomic Medicine are provided here courtesy of Blackwell Publishing

RESOURCES